| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/26/2008 | WO2005076981A3 Methods and compositions related to neuronal differentiation |
| 06/26/2008 | US20080153926 Methods and compositions for modulating mitochondrial alderhyde dehydrogenase-2 |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |
| 06/26/2008 | US20080153745 Compositions of tRNA and uses thereof |
| 06/26/2008 | US20080153166 Stable lipid-comprising drug delivery complexes and methods for their production |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153083 Settings for recombinant adenoviral-based vaccines |
| 06/26/2008 | US20080152700 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a c-Ha-ras gene and the second hybridizing to an oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152670 Attenuated; comprising at least two types of foreign genes inserted to allow expression into two different regions in a recombinant feline herpesvirus type 1 genome; one region encodes thymidine kinase; no lethal effect on the proliferation of the virus in the feline herpesvirus 1 genome |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152647 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 06/26/2008 | US20080152639 Using enzyme mixtures to control concentration of small leucine rich proteoglycans (SLRPs) and glycosaminoglycans in tissues and treat and prevent skin disorders |
| 06/26/2008 | US20080152633 Flavivirus Replicon Constructs for Tumor Therapy |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152623 Using expression vector comprising nucleotide sequences coding secreted protease inhibitor domain proteins as therapeutic tool in treatment of obstructive respiratory disorders |
| 06/26/2008 | CA2672784A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935978A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 06/25/2008 | EP1935976A1 Transfected myeloid-like cells for the treatment of retinopathy of prematurity and related diseases |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1934360A2 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
| 06/25/2008 | EP1934359A2 Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 06/25/2008 | EP1933881A2 Solid polymer delivery compositions and methods for use thereof |
| 06/25/2008 | EP1667730A4 Compositions and methods for treating inflammatory lung disease |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP0988051B1 Lyme combination compositions and uses |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208108A Gene therapy for spinal disorders |
| 06/25/2008 | CN101205545A Recombinant baculoviral for expressing grass carp reovirus external casing protein and construction thereof |
| 06/25/2008 | CN101205544A Tumor targeting recombinant newcastle disease viruses and construction method thereof |
| 06/25/2008 | CN101205542A Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof |
| 06/25/2008 | CN101205539A Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines |
| 06/25/2008 | CN101205538A Clone, expression and use of Schistosoma Japonicum signal transduction protein Sjwnt-4 gene |
| 06/25/2008 | CN101204584A Tumor vaccine using salmonella as carrier and preparation method thereof |
| 06/25/2008 | CN101204583A Application of PDCD4 regroup expression vector on process for preparing medicine curing glioma |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100397078C Method for identifying substances |
| 06/25/2008 | CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390891 Affect aging and/or proliferation of cells in the human |
| 06/24/2008 | US7390884 Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 06/24/2008 | US7390646 Bacterial vectors and methods of use thereof |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390494 Vaccine comprises nucleic acid encodes an immunogenic protein that induces a protective response effective against infection by a piglet weight loss disease circovirus; structural and non-structural polypeptides, vectors, and cells transformed by the vectors; kits for diagnosing |
| 06/24/2008 | US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders |
| 06/24/2008 | US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/24/2008 | US7390482 Drug for auditory dysfunction |
| 06/19/2008 | WO2008073959A2 Synthetic agonists of tlr9 |
| 06/19/2008 | WO2008073856A2 Delivery of nanoparticles and/or agents to cells |
| 06/19/2008 | WO2008073661A2 Long term disease modification using immunostimulatory oligonucleotides |
| 06/19/2008 | WO2008073660A1 Molecules and methods for treatment and detection of cancer |
| 06/19/2008 | WO2008073154A2 Methods and compositions for treating disease |
| 06/19/2008 | WO2008073130A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors |
| 06/19/2008 | WO2008072781A1 Method for prevention or treatment of memory disorder in mammal |
| 06/19/2008 | WO2008071771A2 Inhibition of gpr4 |
| 06/19/2008 | WO2008071093A1 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 06/19/2008 | US20080147045 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146518 Cationic Lipids for the Transfection of Nucleic Acids |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080145938 Buffer solution for electroporation and a method comprising the use of the same |
| 06/19/2008 | US20080145889 Using pancreatic inslet stem cell as drug testing models; tissue engineering and regenerative medicine |
| 06/19/2008 | US20080145859 Diagnosis and treatment of cancer |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145387 N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(-9-tetradeceneyloxy)-1 -propanaminium salt; cytofectin and lipid mixture |
| 06/19/2008 | US20080145385 Dna vaccine as immunoprophylaxis against kala-azar |
| 06/19/2008 | US20080145382 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators, antitumor agents; treating feline viral diseases; veterinary medicine |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145361 Uses of mammalian cytokine; related reagents |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145354 Polyoxyethylene glycol; biocompatability; bioavailability |
| 06/19/2008 | US20080145348 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | US20080145346 Using modulators of heterogeneous nuclear ribonucleoprotein (hnRNP) K binding as therapeutic in treatment of viral diseases |
| 06/19/2008 | US20080145340 Neuroactive agents and methods of their use |
| 06/19/2008 | US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders |
| 06/19/2008 | US20080141936 Electrospraying apparatus and method for coating particles |
| 06/19/2008 | CA2671850A1 Delivery of nanoparticles and/or agents to cells |
| 06/19/2008 | CA2658836A1 Uses of disease gene promoters for providing therapeutic cell populations |
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932926A2 Method of diagnosing ovarian endometriosis |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | EP1932541A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |